ACTIV-2: A Platform Trial for the Evaluation of Novel Therapeutics for the Treatment of Early COVID-19 in Outpatients.

Authors :: Currier, Judith S
Moser, Carlee
Eron, Joseph J
Chew, Kara W
Smith, Davey M
Javan, Arzhang Cyrus
Wohl, David Alain
Daar, Eric S
Hughes, Michael D
Team, for the ACTIV-2/A5401 Study
Source :: Journal of Infectious Diseases. 2023 Supplement, Vol. 288, pS77-S82. 6p.
Publication Year :: 2023
Abstract: Clinical Trials Registration ClinicalTrials.gov Identifier: NCT04518410. [ABSTRACT FROM AUTHOR]

Subjects :: *COVID-19 treatment
*CLINICAL trial registries
*THERAPEUTICS
*OUTPATIENTS
*MONOCLONAL antibodies

Full Text Access

Tools